GI
GAMMA Investing Portfolio holdings
AUM
$1.99B
1-Year Est. Return
27.28%
This Fund
S&P 500
1 Year Est. Return
+27.28%
AUM
$1.99B
AUM Growth
+$177M
(+9.8%)
Holding
4,203
Top Buys
| 1 | +$10.4M | |
| 2 | +$6.62M | |
| 3 | +$5.14M | |
| 4 |
iShares MSCI Canada ETF
EWC
|
+$4.46M |
| 5 |
Eli Lilly
LLY
|
+$4.44M |
Top Sells
| 1 | +$2.05M | |
| 2 | +$1.19M | |
| 3 | +$955K | |
| 4 |
K
Kellanova
K
|
+$804K |
| 5 |
Kimberly-Clark
KMB
|
+$781K |
Sector Composition
| 1 | Technology | 27.23% |
| 2 | Financials | 12.87% |
| 3 | Consumer Discretionary | 9.03% |
| 4 | Healthcare | 8.77% |
| 5 | Industrials | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Vanguard Total Stock Market ETF
VTI
$570B
| $1.88M | 0.09% |
5,595
-941
|
|
||
177
Emerson Electric
EMR
$77.8B
| $1.85M | 0.09% |
13,919
+807
|
|
||
178
Colgate-Palmolive
CL
$75B
| $1.84M | 0.09% |
23,329
+12,437
|
|
||
179
Stryker
SYK
$140B
| $1.84M | 0.09% |
5,224
-817
|
|
||
180
Starbucks
SBUX
$113B
| $1.82M | 0.09% |
21,626
-430
|
|
||
181
CVS Health
CVS
$99.1B
| $1.82M | 0.09% |
22,920
+3,911
|
|
||
182
Monolithic Power Systems
MPWR
$50.3B
| $1.78M | 0.09% |
1,969
+100
|
|
||
|
FITB
183
Fifth Third Bancorp
FITB
$42.7B
| $1.78M | 0.09% |
38,058
+2,130
|
|
||
184
Pfizer
PFE
$154B
| $1.78M | 0.09% |
71,286
-63
|
|
||
185
Kroger
KR
$46.9B
| $1.76M | 0.09% |
28,149
-515
|
|
||
186
Nasdaq
NDAQ
$50.3B
| $1.75M | 0.09% |
18,058
+1,123
|
|
||
187
Allstate
ALL
$55.1B
| $1.74M | 0.09% |
8,342
+454
|
|
||
188
Seagate
STX
$79B
| $1.74M | 0.09% |
6,303
+606
|
|
||
189
Cigna
CI
$71.6B
| $1.73M | 0.09% |
6,277
+1,083
|
|
||
190
Honeywell
HON
$149B
| $1.73M | 0.09% |
8,855
-904
|
|
||
191
Norfolk Southern
NSC
$68B
| $1.73M | 0.09% |
5,975
+118
|
|
||
192
Dominion Energy
D
$55.6B
| $1.72M | 0.09% |
29,276
+14
|
|
||
193
Truist Financial
TFC
$58.1B
| $1.71M | 0.09% |
34,762
+2,589
|
|
||
194
Vanguard S&P 500 ETF
VOO
$838B
| $1.71M | 0.09% |
2,725
+557
|
|
||
195
D.R. Horton
DHI
$42.7B
| $1.7M | 0.09% |
11,827
+102
|
|
||
196
Aflac
AFL
$57.7B
| $1.7M | 0.09% |
15,425
+1,512
|
|
||
197
Regeneron Pharmaceuticals
REGN
$80.3B
| $1.68M | 0.08% |
2,181
+455
|
|
||
198
Nike
NKE
$84.4B
| $1.67M | 0.08% |
26,195
-6,250
|
|
||
199
Novartis
NVS
$306B
| $1.67M | 0.08% |
12,103
+1,486
|
|
||
200
Synopsys
SNPS
$83.8B
| $1.65M | 0.08% |
3,514
-306
|
|